All In Biotech

Drug Trial Radar · NCT05795465

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

A Phase 2, Two-Part Study to Evaluate the Safety and Tolerability of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

52

Planned (sponsor's estimate)

Start

Apr 4, 2023

Primary completion

Oct 2026

Study completion Dec 2026

Sponsor

Lead sponsor
GEn1E LifesciencesIndustry
Sponsor type
Industry
First posted
Apr 3, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

GEn1E-1124-002 is a two-part Phase 2 study to evaluate the safety and tolerability of GEn-1124 in subjects with ARDS. Treatment with IV infusion dosing as early as possible after ARDS diagnosis. Subjects will be given a second dose approximately 8 hours after the first dose and will continue with twice daily dosing (BID regimen) for 5 days.

Conditions

  • Respiratory Distress Syndrome, Acute

Interventions

  • GEn-1124Drug

    Intravenous infusion

  • PlaceboDrug

    Intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety and tolerability (SAEs and TEAEs) of GEn-1124Time frame: Through study completion, Day 60

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia · Withdrawn

  • University of Kansas Medical Center

    Kansas City, Kansas · Withdrawn

  • University of Maryland Medical Center

    Baltimore, Maryland · Recruiting

  • University of Maryland - Baltimore Washington Medical Center

    Glen Burnie, Maryland · Recruiting

  • Ocean Springs Hospital

    Ocean Springs, Mississippi · Completed

  • Washington University School of Medicine

    St Louis, Missouri · Withdrawn

  • Cooper University Hospital

    Camden, New Jersey · Recruiting

  • The Mount Sinai Hospital

    New York, New York · Withdrawn

  • Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • Houston Methodist Hospital

    Houston, Texas · Withdrawn

  • Intermountain Medical Center

    Murray, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.